tripelennamine has been researched along with Delirium in 2 studies
Tripelennamine: A histamine H1 antagonist with low sedative action but frequent gastrointestinal irritation. It is used to treat ASTHMA; HAY FEVER; URTICARIA; and RHINITIS; and also in veterinary applications. Tripelennamine is administered by various routes, including topically.
Delirium: A disorder characterized by CONFUSION; inattentiveness; disorientation; ILLUSIONS; HALLUCINATIONS; agitation; and in some instances autonomic nervous system overactivity. It may result from toxic/metabolic conditions or structural brain lesions. (From Adams et al., Principles of Neurology, 6th ed, pp411-2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| LOTT, GM | 1 |
| KRUG, ES | 1 |
| GLENN, HR | 1 |
| SPERLING, IL | 1 |
2 other studies available for tripelennamine and Delirium
| Article | Year |
|---|---|
A case report of drug delirium clinically interpreted as being due to pyribenzamine.
Topics: Ambulatory Care Facilities; Delirium; Tripelennamine | 1948 |
Drug delirium due to pyribenzamine. Report of a case with recovery.
Topics: Biological Phenomena; Delirium; Physiological Phenomena; Tripelennamine | 1951 |